Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting serum polyclonal antibody escape to SARS-CoV-2 variants by deep mutational learning.

Cell reports methods·2026
Same author

Modeling chimeric antigen receptor response at the single-cell level with conditional optimal transport.

Cell systems·2026
Same author

Delineating inter- and intra-antibody repertoire evolution with AntibodyForests.

Bioinformatics (Oxford, England)·2025
Same author

Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2.

Cell systems·2025
Same author

Protein language model pseudolikelihoods capture features of in vivo B cell selection and evolution.

Briefings in bioinformatics·2025
Same author

PLMFit: benchmarking transfer learning with protein language models for protein engineering.

Briefings in bioinformatics·2025

Related Experiment Video

Updated: Jul 6, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.8K

Meta learning addresses noisy and under-labeled data in machine learning-guided antibody engineering.

Mason Minot1, Sai T Reddy1

  • 1ETH Zurich, Department of Biosystems Science and Engineering, Basel 4056, Switzerland.

Cell Systems
|January 9, 2024
PubMed
Summary

Meta learning accelerates antibody engineering by effectively utilizing noisy and limited data. This approach reduces experimental screening time and enhances machine learning model robustness for protein sequence-function relationships.

Keywords:
antibody engineeringdeep sequencingmachine learningmeta learningprotein engineering

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.4K

Related Experiment Videos

Last Updated: Jul 6, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.8K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.4K

Area of Science:

  • Biotechnology
  • Computational Biology
  • Immunology

Background:

  • Machine learning in protein engineering requires large, high-quality datasets, which are often difficult to obtain.
  • Existing methods for protein engineering can be labor-intensive, involving extensive experimental screening and data labeling.
  • Meta learning offers a promising solution for learning from limited and noisy data, as demonstrated in other scientific domains.

Purpose of the Study:

  • To apply meta learning strategies to address data limitations in antibody engineering.
  • To expedite antibody engineering workflows by overcoming challenges posed by noisy and under-labeled datasets.
  • To improve the robustness and efficiency of machine learning models in predicting protein sequence-function relationships.

Main Methods:

  • Generation of yeast display antibody mutagenesis libraries.
  • Screening of libraries for target antigen binding followed by deep sequencing.
  • Development of meta learning tasks including learning from noisy data, positive and unlabeled learning, and out-of-distribution learning.

Main Results:

  • Demonstrated the efficacy of meta learning in handling noisy training data.
  • Showcased the potential of meta learning for positive and unlabeled learning scenarios.
  • Indicated that meta learning can improve model performance even with under-labeled data.

Conclusions:

  • Meta learning significantly reduces the experimental screening time needed for antibody engineering.
  • This approach enhances the robustness of machine learning models by effectively training on imperfect datasets.
  • Meta learning provides a powerful framework for advancing machine learning applications in protein engineering.